Literature DB >> 35093302

Interplay between K-RAS and miRNAs.

Bing Shui1, Gaspare La Rocca2, Andrea Ventura2, Kevin M Haigis3.   

Abstract

K-RAS is frequently mutated in cancers, and its overactivation can lead to oncogene-induced senescence (OIS), a barrier to cellular transformation. Feedback onto K-RAS limits its signaling to avoid senescence while achieving the appropriate level of activation that promotes proliferation and survival. Such regulation could be mediated by miRNAs, as aberrant RAS signaling and miRNA activity coexist in several cancers, with miRNAs acting both up- and downstream of K-RAS. Several miRNAs both regulate and are regulated by K-RAS, suggesting a noncoding RNA-based feedback mechanism. Functional interactions between K-RAS and the miRNA machinery have also begun to unfold. This review comprehensively surveys the state of knowledge connecting K-RAS to miRNA function and proposes a model for the regulation of K-RAS signaling by noncoding RNAs.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  K-RAS; cancer; feedback regulation; miRNA

Mesh:

Substances:

Year:  2022        PMID: 35093302      PMCID: PMC9035052          DOI: 10.1016/j.trecan.2022.01.002

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  92 in total

1.  The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans.

Authors:  B J Reinhart; F J Slack; M Basson; A E Pasquinelli; J C Bettinger; A E Rougvie; H R Horvitz; G Ruvkun
Journal:  Nature       Date:  2000-02-24       Impact factor: 49.962

2.  Coordinated Regulation of Cap-Dependent Translation and MicroRNA Function by Convergent Signaling Pathways.

Authors:  Scott H Olejniczak; Gaspare La Rocca; Megan R Radler; Shawn M Egan; Qing Xiang; Ralph Garippa; Craig B Thompson
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

3.  High-Resolution In Vivo Identification of miRNA Targets by Halo-Enhanced Ago2 Pull-Down.

Authors:  Xiaoyi Li; Yuri Pritykin; Carla P Concepcion; Yuheng Lu; Gaspare La Rocca; Minsi Zhang; Bryan King; Peter J Cook; Yu Wah Au; Olesja Popow; Joao A Paulo; Hannah G Otis; Chiara Mastroleo; Paul Ogrodowski; Ryan Schreiner; Kevin M Haigis; Doron Betel; Christina S Leslie; Andrea Ventura
Journal:  Mol Cell       Date:  2020-06-03       Impact factor: 17.970

4.  Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer.

Authors:  Tsuyoshi Hata; Yukako Mokutani; Hidekazu Takahashi; Akira Inoue; Koji Munakata; Kazuya Nagata; Naotsugu Haraguchi; Junichi Nishimura; Taishi Hata; Chu Matsuda; Kohei Murata; Tsunekazu Mizushima; Yuichiro Doki; Masaki Mori; Hirofumi Yamamoto
Journal:  Int J Oncol       Date:  2016-12-20       Impact factor: 5.650

5.  MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.

Authors:  Peter Olson; Jun Lu; Hao Zhang; Anny Shai; Matthew G Chun; Yucheng Wang; Steven K Libutti; Eric K Nakakura; Todd R Golub; Douglas Hanahan
Journal:  Genes Dev       Date:  2009-09-15       Impact factor: 11.361

6.  EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2.

Authors:  Jia Shen; Weiya Xia; Yekaterina B Khotskaya; Longfei Huo; Kotaro Nakanishi; Seung-Oe Lim; Yi Du; Yan Wang; Wei-Chao Chang; Chung-Hsuan Chen; Jennifer L Hsu; Yun Wu; Yung Carmen Lam; Brian P James; Xiuping Liu; Chang-Gong Liu; Dinshaw J Patel; Mien-Chie Hung
Journal:  Nature       Date:  2013-05-01       Impact factor: 49.962

7.  KRAS Engages AGO2 to Enhance Cellular Transformation.

Authors:  Sunita Shankar; Sethuramasundaram Pitchiaya; Rohit Malik; Vishal Kothari; Yasuyuki Hosono; Anastasia K Yocum; Harika Gundlapalli; Yasmine White; Ari Firestone; Xuhong Cao; Saravana M Dhanasekaran; Jeanne A Stuckey; Gideon Bollag; Kevin Shannon; Nils G Walter; Chandan Kumar-Sinha; Arul M Chinnaiyan
Journal:  Cell Rep       Date:  2016-02-04       Impact factor: 9.423

8.  AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer.

Authors:  Jean Ching-Yi Tien; Seema Chugh; Andrew E Goodrum; Yunhui Cheng; Rahul Mannan; Yuping Zhang; Lisha Wang; Vijaya L Dommeti; Xiaoming Wang; Alice Xu; Jennifer Hon; Carson Kenum; Fengyun Su; Rui Wang; Xuhong Cao; Sunita Shankar; Arul M Chinnaiyan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-18       Impact factor: 11.205

9.  Dicer regulates differentiation and viability during mouse pancreatic cancer initiation.

Authors:  John P Morris; Renee Greer; Holger A Russ; Guido von Figura; Grace E Kim; Anke Busch; Jonghyeob Lee; Klemens J Hertel; Seung Kim; Michael McManus; Matthias Hebrok
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

10.  MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.

Authors:  Chuannan Fan; Yancheng Lin; Yubin Mao; Zhengjie Huang; Allan Yi Liu; Handong Ma; Donghong Yu; Alaiyi Maitikabili; Hongjun Xiao; Chuankai Zhang; Fan Liu; Qi Luo; Gaoliang Ouyang
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.